NCAM1 and neuroblastoma: Thus, since CD56 may represent an activation marker on immune cell populations, BM-derived CD56+ EVs from NB patients may be derived from activated cell subsets among BM-resident cells, witnessing a high inflammatory state in the BM microenvironment of NB patients which is lacking in healthy subjects.